Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATG7 | O95352 | 13/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | EIF4E | P06730 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | TOP1 | P11387 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | PNP | P00491 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24024488 | 0.90 | LMNA (0.69) | ATG7LMNASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL7572340 | 0.90 | LMNA (0.69) | ATG7LMNASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL9780402 | 0.82 | ATG7 (0.58) | ATG7CA1CA2CA4CA9 | |
| SCHEMBL21887967 | 0.81 | ATG7 (0.40) | ATG7LMNASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL9780432 | 0.81 | LMNA (0.76) | LMNASMN1; SMN2ALDH1A1GLAEIF4E | |
| SCHEMBL11834477 | 0.78 | LMNA (0.49) | LMNASMN1; SMN2ALDH1A1GLAEIF4E | |
| SCHEMBL21888108 | 0.76 | ATG7 (0.37) | ATG7LMNASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL21888937 | 0.75 | ATG7 (0.36) | ATG7LMNASMN1; SMN2ALDH1A1GLA | |
| SCHEMBL12151510 | 0.74 | LMNA (0.73) | LMNASMN1; SMN2ALDH1A1GLAEIF4E | |
| SCHEMBL25520855 | 0.74 | LMNA (0.73) | LMNASMN1; SMN2ALDH1A1GLAEIF4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119667132-A | Semisynthetic nanopore, preparation method thereof and protein sequencing method | 西安电子科技大学 | 2025-03-21 | — | — | CN | claimed |
| US-4992426-A | Antiparasitic 5'-sulfamoyl nucleosides | NUCLEIC ACID RESEARCH INSTITUTE (US) | 1991-02-12 | — | — | US | claimed |
| US-20260128214-A1 | METHODS AND APPARATUS FOR MAINTAINING ELECTRIC VEHICLE BATTERY AT ITS OPTIMAL OPERATING AND CHARGING TEMPERATURE | OMNITEK PARTNERS LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260111863-A1 | System and Process for Providing an NFT Ricardian contract | BERNARDI ROBERT (US) | 2026-04-23 | — | — | US | disclosed |
| US-12524507-B2 | Secure web RTC Real Time Communications Service for audio and video streaming communications | Myseum, Inc. (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4627692-A1 | METHODS AND DEVICES FOR DETERMINING AC FREQUENCY FOR PEAK HEATING A BATTERY HAVING AN ELECTROLYTE | Omnitek Partners LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12408449-B2 | Photodiode device with improved dark current | AMS-OSRAM AG (AT) | 2025-09-02 | — | — | US | disclosed |
| CN-119986715-A | Clock self-calibration method, device and equipment of receiver | 千寻位置网络(北京)有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119667132-A | Semisynthetic nanopore, preparation method thereof and protein sequencing method | 西安电子科技大学 | 2025-03-21 | — | — | CN | disclosed |
| US-12239619-B2 | Composition for inducing pili formation in bacterium of genus Bifidobacterium | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2025-03-04 | — | — | US | disclosed |
| CN-118940198-B | LED backlight heat dissipation analysis method | 深圳市威天光电科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-11448314-B2 | Method of determining at least one shift parameter of a vehicle transmission | DANA BELGIUM N.V. (BE) | 2022-09-20 | — | — | US | disclosed |
| CN-114650258-A | Message processing method and device | 深圳市海思半导体有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20220133665-A1 | COMPOSITION FOR INDUCING PILI FORMATION IN BACTERIUM OF GENUS BIFIDOBACTERIUM | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2022-05-05 | — | — | US | disclosed |
| US-20220107994-A1 | SECURE WEB RTC REAL TIME COMMUNICATIONS SERVICE FOR AUDIO AND VIDEO STREAMING COMMUNICATIONS | AVILA TECH LLC (US) | 2022-04-07 | — | — | US | disclosed |
| CN-114107135-A | Enterococcus faecalis for treating colitis | 苏州普瑞森生物科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20210353660-A1 | Pre-Activated Nucleoside IMPDH Inhibitors As Anti-Infective Drugs | OCTAGON THERAPEUTICS INC. (US) | 2021-11-18 | — | — | US | disclosed |
| WO-2020072931-A2 | PRE-ACTIVATED NUCLEOSIDE IMPDH INHIBITORS AS ANTI-INFECTIVE DRUGS | OCTAGON THERAPEUTICS INC. (US) | 2020-04-09 | — | — | WO | disclosed |
| US-4992426-A | Antiparasitic 5'-sulfamoyl nucleosides | NUCLEIC ACID RESEARCH INSTITUTE (US) | 1991-02-12 | — | — | US | disclosed |
| US-4992426-A | Antiparasitic 5'-sulfamoyl nucleosides | NUCLEIC ACID RESEARCH INSTITUTE (US) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220133665-A1 | COMPOSITION FOR INDUCING PILI FORMATION IN BACTERIUM OF GENUS BIFIDOBACTERIUM | FABP2, HPD, SI | ATG7 2894/4885LMNA 3591/4885SMN1; SMN2 4684/4885 |
| US-20260111863-A1 | System and Process for Providing an NFT Ricardian contract | SQSTM1, NUDC, TIMM13 | ATG7 147/4885LMNA 1495/4885SMN1; SMN2 596/4885 |
| US-12239619-B2 | Composition for inducing pili formation in bacterium of genus Bifidobacterium | FABP2, HPD, SI | ATG7 2894/4885LMNA 3591/4885SMN1; SMN2 4684/4885 |
| US-20210353660-A1 | Pre-Activated Nucleoside IMPDH Inhibitors As Anti-Infective Drugs | IMPDH1, IMPDH2, PNP | ATG7 2950/4885LMNA 1199/4885SMN1; SMN2 4411/4885 |
| US-20260128214-A1 | METHODS AND APPARATUS FOR MAINTAINING ELECTRIC VEHICLE BATTERY AT ITS OPTIMAL OPERATING AND CHARGING TEMPERATURE | TMEM109, LSM12, TMCO1 | ATG7 1196/4885LMNA 974/4885SMN1; SMN2 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.